rs752375653
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PP5_Moderate
The NM_001130144.3(LTBP3):c.2216del(p.Gly739AlafsTer7) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000189 in 1,537,770 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 0 hom. )
Consequence
LTBP3
NM_001130144.3 frameshift
NM_001130144.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.99
Genes affected
LTBP3 (HGNC:6716): (latent transforming growth factor beta binding protein 3) The protein encoded by this gene forms a complex with transforming growth factor beta (TGF-beta) proteins and may be involved in their subcellular localization. Activation of this complex requires removal of the encoded binding protein. This protein also may play a structural role in the extracellular matrix. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
?
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
?
Variant 11-65546811-GC-G is Pathogenic according to our data. Variant chr11-65546811-GC-G is described in ClinVar as [Pathogenic]. Clinvar id is 204496.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LTBP3 | NM_001130144.3 | c.2216del | p.Gly739AlafsTer7 | frameshift_variant | 15/28 | ENST00000301873.11 | |
LTBP3 | NM_021070.4 | c.2216del | p.Gly739AlafsTer7 | frameshift_variant | 15/27 | ||
LTBP3 | NM_001164266.1 | c.1865del | p.Gly622AlafsTer7 | frameshift_variant | 15/27 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LTBP3 | ENST00000301873.11 | c.2216del | p.Gly739AlafsTer7 | frameshift_variant | 15/28 | 2 | NM_001130144.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000273 AC: 4AN: 146426Hom.: 0 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
4
AN:
146426
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000294 AC: 7AN: 238376Hom.: 0 AF XY: 0.0000306 AC XY: 4AN XY: 130688
GnomAD3 exomes
AF:
AC:
7
AN:
238376
Hom.:
AF XY:
AC XY:
4
AN XY:
130688
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000180 AC: 25AN: 1391344Hom.: 0 Cov.: 36 AF XY: 0.0000130 AC XY: 9AN XY: 691906
GnomAD4 exome
AF:
AC:
25
AN:
1391344
Hom.:
Cov.:
36
AF XY:
AC XY:
9
AN XY:
691906
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000273 AC: 4AN: 146426Hom.: 0 Cov.: 32 AF XY: 0.0000140 AC XY: 1AN XY: 71444
GnomAD4 genome
?
AF:
AC:
4
AN:
146426
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
71444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Brachyolmia-amelogenesis imperfecta syndrome Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Sep 01, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.003%). Frameshift variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with LTBP3 -related disorder (ClinVar ID: VCV000204496 / PMID: 25669657). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2015 | - - |
Pathogenic, no assertion criteria provided | research | Institute of Human Genetics, University of Ulm | Nov 17, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at